{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:22:39Z","timestamp":1777933359256,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Antipsychotic drugs are prescription-only-medications which require valid prescriptions before it can be obtained from a pharmacy. On the other hand, community pharmacists in developing countries have sometimes been implicated in over-the-counter dispensing of prescription-only-medications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>This study investigated the accessibility of antipsychotic drugs without prescriptions from community pharmacies, and the factors responsible for the over-the-counter dispensing of antipsychotics by community pharmacists.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An exploratory cross-sectional mixed method survey design using pretested structured questionnaires among 119 community pharmacists, simulated patients in 119 community pharmacies, and one-on-one in-depth interview among eleven (11) community pharmacist-owners\/superintendent pharmacists were utilized for data collection. The knowledge of the pharmacists on antipsychotics including classification, side effects, and dispensing practices were explored. Qualitative data was analyzed with thematic analysis, while quantitative data was analyzed using descriptive statistics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Majority of the community pharmacists (87.4%) showed good knowledge of antipsychotics as it relates to the different classes and the side effects peculiar to each class. Antipsychotic medications were dispensed by 85 (71.4%) of community pharmacists without a prescription. One-on-one in-depth interview sessions with community pharmacist owners\/superintendent pharmacists demonstrated that community pharmacists are knowledgeable about antipsychotics and their side effects. Reasons given for dispensing this class of drugs without prescription included emergencies, and knowledge of the person as being on the drugs long-term. About 4% pharmacists were adamant on dispensing only with prescription.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Community pharmacists in Ibadan metropolis readily dispense antipsychotics without valid prescriptions despite having an optimal knowledge about the negative implications of doing so. This could be due to weak legislation and regulation of drug laws. There is a need for more stringent regulations as well as adequate sensitization about the negative effects of inappropriate dispensing of prescription-only-medications.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-023-10480-0","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T14:02:21Z","timestamp":1703167341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Knowledge and dispensing practice of community pharmacists towards antipsychotic medicines in a Nigerian metropolitan city \u2013 a cross-sectional study"],"prefix":"10.1186","volume":"23","author":[{"given":"Joseph","family":"Olasupo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faith","family":"Taiwo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinniyi","family":"Aje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Titilayo O.","family":"Fakeye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"key":"10480_CR1","unstructured":"Finkel R, Clark MA, Cubeddu LX, editors. Pharmacology. Lippincott Williams & Wilkins; 2009."},{"key":"10480_CR2","unstructured":"Maglione M, Maher AR, Hu J, Wang Z, Shanman R, Shekelle PG, Roth B, Hilton L, Suttorp MJ, Ewing BA, Motala A. Off-label use of atypical antipsychotics: an update. Agency for Healthcare Research and Quality (US); 2011."},{"issue":"6","key":"10480_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.euroneuro.2011.12.008","volume":"22","author":"EJ Liemburg","year":"2012","unstructured":"Liemburg EJ, Knegtering H, Klein HC, Kortekaas R, Aleman A. Antipsychotic medication and prefrontal cortex activation: a review of neuroimaging findings. Eur Neuropsychopharmacol. 2012;22(6):387\u2013400.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"10480_CR4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1192\/bjp.bp.109.066217","volume":"196","author":"NA Crossley","year":"2010","unstructured":"Crossley NA, Constante M, McGuire P, Power P. Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis. Br J Psychiatry. 2010;196(6):434\u20139.","journal-title":"Br J Psychiatry"},{"issue":"9","key":"10480_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.euroneuro.2009.04.008","volume":"19","author":"B Vitiello","year":"2009","unstructured":"Vitiello B, Correll C, van Zwieten-Boot B, Zuddas A, Parellada M, Arango C. Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns. Eur Neuropsychopharmacol. 2009;19(9):629\u201335.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"10480_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.euroneuro.2013.09.003","volume":"24","author":"A Gallini","year":"2014","unstructured":"Gallini A, Andrieu S, Donohue JM, Oumouhou N, Lapeyre-Mestre M, Gardette V. Trends in use of antipsychotics in elderly patients with Dementia: impact of national safety warnings. Eur Neuropsychopharmacol. 2014;24(1):95\u2013104.","journal-title":"Eur Neuropsychopharmacol"},{"key":"10480_CR7","doi-asserted-by":"crossref","unstructured":"Divac N, Prostran M, Jakovcevski I, Cerovac N. Second-generation antipsychotics and extrapyramidal adverse effects. BioMed research international. 2014;2014.","DOI":"10.1155\/2014\/656370"},{"issue":"5","key":"10480_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1192\/bjp.bp.111.101485","volume":"200","author":"MJ Peluso","year":"2012","unstructured":"Peluso MJ, Lewis SW, Barnes TR, Jones PB. Extrapyramidal motor side-effects of first-and second-generation antipsychotic Drugs. Br J Psychiatry. 2012;200(5):387\u201392.","journal-title":"Br J Psychiatry"},{"key":"10480_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2165\/00023210-200216010-00003","volume":"16","author":"D Tarsy","year":"2002","unstructured":"Tarsy D, Baldessarini RJ, Tarazi FI. Effects of newer antipsychotics on extrapyramidal function. CNS Drugs. 2002;16:23\u201345.","journal-title":"CNS Drugs"},{"key":"10480_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11892-010-0112-8","volume":"10","author":"M Hasnain","year":"2010","unstructured":"Hasnain M, Fredrickson SK, Vieweg WV, Pandurangi AK. Metabolic syndrome associated with schizophrenia and atypical antipsychotics. Curr Diab Rep. 2010;10:209\u201316.","journal-title":"Curr Diab Rep"},{"issue":"5","key":"10480_CR11","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/MED.0b013e32833de61c","volume":"17","author":"P Pramyothin","year":"2010","unstructured":"Pramyothin P, Khaodhiar L. Metabolic syndrome with the atypical antipsychotics. Curr Opin Endocrinol Diabetes Obes. 2010;17(5):460\u20136.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"10480_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.schres.2005.12.855","volume":"83","author":"MA De Hert","year":"2006","unstructured":"De Hert MA, van Winkel R, Van Eyck D, Hanssens L, Wampers M, Scheen A, Peuskens J. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophr Res. 2006;83(1):87\u201393.","journal-title":"Schizophr Res"},{"issue":"3","key":"10480_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/ph14030238","volume":"14","author":"M Carli","year":"2021","unstructured":"Carli M, Kolachalam S, Longoni B, Pintaudi A, Baldini M, Aringhieri S, Fasciani I, Annibale P, Maggio R, Scarselli M. Atypical antipsychotics and metabolic syndrome: from molecular mechanisms to clinical differences. Pharmaceuticals. 2021;14(3):238.","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10480_CR14","first-page":"617","volume":"81","author":"J Muench","year":"2010","unstructured":"Muench J, Hamer AM. Adverse effects of antipsychotic medications. Am Family Phys. 2010;81(5):617\u201322.","journal-title":"Am Family Phys"},{"key":"10480_CR15","doi-asserted-by":"publisher","first-page":"569912","DOI":"10.3389\/fpsyt.2020.569912","volume":"11","author":"L Brandt","year":"2020","unstructured":"Brandt L, Bschor T, Henssler J, M\u00fcller M, Hasan A, Heinz A, Gutwinski S. Antipsychotic withdrawal symptoms: a systematic review and meta-analysis. Front Psychiatry. 2020;11:569912.","journal-title":"Front Psychiatry"},{"issue":"5","key":"10480_CR16","first-page":"77","volume":"10","author":"GT Bogart","year":"2011","unstructured":"Bogart GT. Abuse of second-generation antipsychotics: what prescribers need to know. Curr Psychiatry. 2011;10(5):77\u201380.","journal-title":"Curr Psychiatry"},{"key":"10480_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pnpbp.2013.06.008","volume":"52","author":"AN Samaha","year":"2014","unstructured":"Samaha AN. Can antipsychotic treatment contribute to drug addiction in schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry. 2014;52:9\u201316.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10480_CR18","doi-asserted-by":"publisher","first-page":"112598","DOI":"10.1016\/j.psychres.2019.112598","volume":"281","author":"J Zhu","year":"2019","unstructured":"Zhu J, Hou W, Xu Y, Ji F, Wang G, Chen C, Lin C, Lin X, Li J, Zhuo C, Shao M. Antipsychotic Drugs and Sudden Cardiac Death: a literature review of the challenges in the prediction, management, and future steps. Psychiatry Res. 2019;281:112598.","journal-title":"Psychiatry Res"},{"issue":"1","key":"10480_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11606-007-0428-5","volume":"23","author":"M Cepoiu","year":"2008","unstructured":"Cepoiu M, McCusker J, Cole MG, Sewitch M, Belzile E, Ciampi A. Recognition of depression by non-psychiatric physicians\u2013a systematic literature review and meta-analysis. J Gen Intern Med. 2008;23(1):25\u201336.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10480_CR20","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/ijerph18020749","volume":"18","author":"M Marchi","year":"2021","unstructured":"Marchi M, Magarini FM, Mattei G, Pingani L, Moscara M, Galeazzi GM, Ferrari S. Diagnostic agreement between physicians and a consultation\u2013liaison psychiatry team at a general hospital: an exploratory study across 20 years of referrals. Int J Environ Res Public Health. 2021;18(2):749.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10480_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12991-018-0176-4","volume":"17","author":"C L\u00fccke","year":"2018","unstructured":"L\u00fccke C, Gschossmann JM, Gr\u00f6mer TW, Moeller S, Schneider CE, Zikidi A, Philipsen A, M\u00fcller HH. Off-label prescription of psychiatric Drugs by non-psychiatrist physicians in three general hospitals in Germany. Ann Gen Psychiatry. 2018;17(1):1\u20137.","journal-title":"Ann Gen Psychiatry"},{"issue":"2","key":"10480_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.31254\/jsir.2014.3222","volume":"3","author":"O Akinyandenu","year":"2014","unstructured":"Akinyandenu O, Akinyandenu A. Irrational use and non-prescription sale of antibiotics in Nigeria, a need for change. J Sci Innov Res. 2014;3(2):251\u20137.","journal-title":"J Sci Innov Res"},{"key":"10480_CR23","first-page":"412","volume":"2","author":"L Amadi","year":"2014","unstructured":"Amadi L, Amadi M. Sustainable drug consumption, regulatory dynamics and fake drug repositioning in Nigeria: a case of NAFDAC. Sci-Afric J Sci Issues Res Essays. 2014;2:412\u20139.","journal-title":"Sci-Afric J Sci Issues Res Essays"},{"key":"10480_CR24","doi-asserted-by":"crossref","unstructured":"Mekonnen GB, Beyna AT. Pharmacists\u2019 knowledge and practice of issues related to using psychotropic medication in elderly people in Ethiopia: a prospective cross-sectional study. BioMed Research International. 2020;2020.","DOI":"10.1155\/2020\/7695692"},{"issue":"4","key":"10480_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.japh.2018.04.035","volume":"58","author":"EV Mooney","year":"2018","unstructured":"Mooney EV, Hamper JG, Willis RT, Farinha TL, Ricchetti CA. Evaluating patient satisfaction with pharmacist-administered long-acting injectable antipsychotics in the community pharmacy. J Am Pharmacists Association. 2018;58(4):24\u20139.","journal-title":"J Am Pharmacists Association"},{"key":"10480_CR26","doi-asserted-by":"crossref","unstructured":"Dameh M, Green J, Norris P. Over-the-counter sales of antibiotics from community pharmacies in Abu Dhabi. Pharmacy World & Science. 2010;32:643\u2009\u2013\u200950.","DOI":"10.1007\/s11096-010-9418-5"},{"issue":"3","key":"10480_CR27","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/MOP.0b013e32814b09cf","volume":"19","author":"DA Levine","year":"2007","unstructured":"Levine DA. Pharming\u2019: the abuse of prescription and over-the-counter Drugs in teens. Curr Opin Pediatr. 2007;19(3):270\u20134.","journal-title":"Curr Opin Pediatr"},{"key":"10480_CR28","doi-asserted-by":"crossref","unstructured":"Evans EA, Sullivan MA. Abuse and misuse of antidepressants. Subst Abuse Rehabilitation 2014 Aug 14:107\u201320.","DOI":"10.2147\/SAR.S37917"},{"issue":"5","key":"10480_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.18773\/austprescr.2015.055","volume":"38","author":"J Brett","year":"2015","unstructured":"Brett J, Murnion B. Management of benzodiazepine misuse and dependence. Australian Prescriber. 2015;38(5):152.","journal-title":"Australian Prescriber"},{"key":"10480_CR30","first-page":"222","volume":"6","author":"SA Bawazir","year":"1992","unstructured":"Bawazir SA. Prescribing pattern at community pharmacies in Saudi Arabia. Int Pharm J. 1992;6:222\u20133.","journal-title":"Int Pharm J"},{"issue":"15","key":"10480_CR31","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/ajhp\/60.15.1591","volume":"60","author":"L Matowe","year":"2003","unstructured":"Matowe L, Al-Kandery AS, Bihzad SM. Pharmacy in Kuwait. Am J Health-System Pharm. 2003;60(15):1591\u20132.","journal-title":"Am J Health-System Pharm"},{"issue":"9","key":"10480_CR32","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3109\/10826080802490683","volume":"45","author":"A Albsoul-Younes","year":"2010","unstructured":"Albsoul-Younes A, Wazaify M, Yousef AM, Tahaineh L. Abuse and misuse of prescription and nonprescription Drugs sold in community pharmacies in Jordan. Subst Use Misuse. 2010;45(9):1319\u201329.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"10480_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jinf.2018.07.001","volume":"78","author":"A Auta","year":"2019","unstructured":"Auta A, Hadi MA, Oga E, Adewuyi EO, Abdu-Aguye SN, Adeloye D, Strickland-Hodge B, Morgan DJ. Global access to antibiotics without prescription in community pharmacies: a systematic review and meta-analysis. J Infect. 2019;78(1):8\u201318.","journal-title":"J Infect"},{"issue":"10","key":"10480_CR34","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1086\/598183","volume":"48","author":"C Llor","year":"2009","unstructured":"Llor C, Cots JM. The sale of antibiotics without prescription in pharmacies in Catalonia, Spain. Clin Infect Dis. 2009;48(10):1345\u20139.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10480_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jsps.2011.11.003","volume":"21","author":"A Al-Mohamadi","year":"2013","unstructured":"Al-Mohamadi A, Badr A, Mahfouz LB, Samargandi D, Al Ahdal A. Dispensing medications without prescription at Saudi community pharmacy: extent and perception. Saudi Pharm J. 2013;21(1):13\u20138.","journal-title":"Saudi Pharm J"},{"issue":"4","key":"10480_CR36","doi-asserted-by":"publisher","first-page":"338","DOI":"10.17712\/nsj.2016.4.20160245","volume":"21","author":"FD Alosaimi","year":"2016","unstructured":"Alosaimi FD, Alruwais FS, Alanazi FA, Alabidi GA, Aljomah NA, Alsalameh NS. Patients reasons for obtaining psychotropic medications without a prescription at retail pharmacies in Central Saudi Arabia. Neurosciences J. 2016;21(4):338\u201344.","journal-title":"Neurosciences J"},{"issue":"2","key":"10480_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.2042-7174.2000.tb00990.x","volume":"8","author":"D Hibbert","year":"2000","unstructured":"Hibbert D, Rees JA, Smith I. Ethical awareness of community pharmacists. Int J Pharm Pract. 2000;8(2):82\u20137.","journal-title":"Int J Pharm Pract"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-10480-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-023-10480-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-10480-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T14:04:19Z","timestamp":1703167459000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-023-10480-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["10480"],"URL":"https:\/\/doi.org\/10.1186\/s12913-023-10480-0","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,21]]},"assertion":[{"value":"12 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval numbers UI\/EC\/21\/205 and UI\/EC\/21\/0212 were obtained from the University of Ibadan\/University College Hospital Institutional Review Board. All participants i.e. the community pharmacists (who filled the questionnaires) and the superintendent pharmacists\/pharmacist-owners who were interviewed gave their informed consent. All the methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1450"}}